Frankfurt - Delayed Quote EUR

Dermapharm Holding SE (DMP.F)

Compare
37.30 +0.85 (+2.33%)
As of 8:10 AM GMT+1. Market Open.
Loading Chart for DMP.F
DELL
  • Previous Close 36.45
  • Open 37.30
  • Bid 37.40 x --
  • Ask 38.00 x --
  • Day's Range 37.30 - 37.30
  • 52 Week Range 29.90 - 42.68
  • Volume 60
  • Avg. Volume 118
  • Market Cap (intraday) 2.055B
  • Beta (5Y Monthly) 1.14
  • PE Ratio (TTM) 22.20
  • EPS (TTM) 1.68
  • Earnings Date Nov 14, 2024
  • Forward Dividend & Yield 0.88 (2.57%)
  • Ex-Dividend Date Jun 28, 2024
  • 1y Target Est 47.62

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany. The company operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, Herpotherm, and epiivo brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG.

ir.dermapharm.de

3,603

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DMP.F

View More

Performance Overview: DMP.F

Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

DMP.F
9.75%
DAX P
14.94%

1-Year Return

DMP.F
5.65%
DAX P
21.09%

3-Year Return

DMP.F
49.39%
DAX P
19.14%

5-Year Return

DMP.F
15.81%
DAX P
46.55%

Compare To: DMP.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DMP.F

View More

Valuation Measures

Annual
As of 11/21/2024
  • Market Cap

    1.96B

  • Enterprise Value

    2.88B

  • Trailing P/E

    21.70

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.70

  • Price/Book (mrq)

    3.36

  • Enterprise Value/Revenue

    2.49

  • Enterprise Value/EBITDA

    9.65

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.24%

  • Return on Assets (ttm)

    5.71%

  • Return on Equity (ttm)

    15.00%

  • Revenue (ttm)

    1.15B

  • Net Income Avi to Common (ttm)

    83.04M

  • Diluted EPS (ttm)

    1.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    165.76M

  • Total Debt/Equity (mrq)

    193.81%

  • Levered Free Cash Flow (ttm)

    155.19M

Research Analysis: DMP.F

View More

Company Insights: DMP.F

Research Reports: DMP.F

View More

People Also Watch